Homogeneity and stability of flexible perovskite solar cells (PSCs) are significant for the commercial feasibility in upscaling fabrication. Concretely, the mismatching between bottom interface and perovskite precursor ink can cause uncontrollable crystallization and undesired dangling bonds during the printing process. Herein, methylammonium acetate, serving as ink assistant (IAS) can effectively avoid the micron-scale defects of perovskite film. The in situ optical microscope is applied to prove the IAS can inhibit the colloidal aggregation and induce more adequate crystallization growth, thus avoiding the micron-scale defects of pinholes and intergranular cracking. Concurrently, 4-chlorobenzenesulfonic acid is introduced into the electrode surface as a passivation layer to restore the deep traps at perovskite interface in nanoscale. Finally, the target flexible devices (1.01 cm 2 ) deliver a superior efficiency of 18.12% with improved air atmosphere stability. This multi-scale defect repair strategy provides an integrated design concept of homogeneity and stability for scalable and flexible PSCs.

Highly efficient and stable quasi-2D hybrid perovskite solar cells (PSCs) using hydrophobic 4-(trifluoromethyl) benzylamine (4TFBZA) as the spacer cation are successfully demonstrated. It is found that the incorporation of hydrophobic 4TFBZA into MAPbI 3 can effectively induce a spontaneous upper gradient 2D (SUG-2D) structure, passivate the trap states, and restrain the ion motion. Meanwhile, the strong hydrogen bonding of F•••HN between 4TFBZA ions and methylamine ions can effectively suppress the decomposition of perovskite, which gives the device a better thermal stability. Besides, due to the SUG-2D structure with hydrophobic 4TFBZA, the device also exhibits a better moisture stability. The SUG-2D-structure-based device exhibits a power conversion efficiency of 17.07% with a high open-circuit voltage of 1.10 V and a notable fill factor of 71%. This work provides a new strategy for constructing efficient and stable quasi-2D PSCs, and it is an inspiration for the packaging strategy of perovskites.

Genome-wide association studies and integrative genomics approaches have demonstrated significant associations between chronic obstructive pulmonary disease (COPD) and single-nucleotide polymorphisms (SNPs) in the chromosome 15q25 region that includes iron-responsive element binding protein 2 gene (IREB2) and CHRNA3/5 in non-Asian populations. We investigated whether IREB2 and CHRNA3/5 polymorphisms would be associated with COPD susceptibility and COPD-related phenotypes in a Chinese Han population. Eight SNPs (rs2568494, rs2656069, rs10851906, rs1964678, rs12593229, rs965604, rs13180, rs17483929) in IREB2 gene and four SNPs (rs16969968, rs1051730, rs938682, rs8034191) in or near CHRNA3/5 locus were genotyped in a case-control study (680 COPD patients and 687 controls). No significant associations were found between any of the SNPs and COPD in either former-smokers or current-smokers. Two SNPs (rs2656069 and rs10851906) in IREB2 were associated with COPD (P ¼ 0.045 and 0.032, respectively) in non-smoker. Four SNPs (rs1964678, rs12593229, rs965604 and rs13180) in IREB2 were associated with forced expiratory volume in 1 s (FEV 1 )% predicted and three SNPs (rs16969968, rs8034191 and rs1051730) in CHRNA3/5 were both associated with FEV 1 % predicted and FEV 1 /FVC in COPD cases (P range 0.007-0.050). The SNP rs8034191 near CHRNA3/5 locus was significantly associated with pack-years of smoking in COPD patients (P ¼ 0.033). We demonstrated IREB2 polymorphisms were associated with COPD in non-smoking subjects, and the effect of IREB2 gene on COPD may be independent from smoking and independent from CHRNA3/5 gene cluster. Besides, we confirmed that SNPs in these two gene loci were associated with pulmonary function and CHRNA3/5 polymorphism was associated with pack-year of smoking in COPD patients in the Chinese Han population.

No abstract

Aminoguanidine hydrochloride passivated Sn-perovskite with a power conversion efficiency of 7.3%.

Solution processing of perovskite solar cells (PSCs) is highly promising for the high‐throughput production of cost‐effective devices. Although PSCs have achieved great advances in power conversion efficiency, challenges still remain in the reproducibility of high‐quality perovskite thin film with simultaneously improved precursor solution stability. Here, a reactive inhibition strategy by introducing diethyl (hydroxymethyl) phosphonate (DHP) in perovskite precursor solution is successfully employed to improve the stability of precursor solution and the performance of corresponding device. DHP inhibits the reactivity of the iodide and formamidinium ions through multiple chemical bonds, ensuring the stability of the precursor solution. In addition, due to chelation interaction of Pb2+ with the oxygen of PO in DHP, the DHP in the perovskite film improves the film quality with desired stoichiometry by reducing the defects and the content of lead iodide. The DHP‐doped precursor solution and corresponding devices show excellent performance reproducibility and super stability under ambient conditions for more than 50 days, which illustrates the commercial feasibility for scalable fabrication.

Polycrystalline perovskite films generally have high-density defects due to the numerous crystal nucleus and randomly oriented fine grains in the film formation. These defects are commonly regarded as the source...

No abstract